Hektas Ticaret T.A.S. (IBSE:HEKTS) decided to acquire ARMA ILAÇ on December 31, 2020.Hektas Ticaret T.A.S. (IBSE:HEKTS) agreed to acquire ARMA ILAÇ from OYAK BIYOTEKNOLOJI for TRY 92 million on July 28, 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.39 TRY | +0.39% | +1.25% | -23.43% |
1st Jan change | Capi. | |
---|---|---|
-23.43% | 1.19B | |
+14.29% | 38.28B | |
-.--% | 11.12B | |
-7.38% | 7.29B | |
+6.91% | 6.83B | |
-3.47% | 6.02B | |
-4.84% | 5.61B | |
-11.04% | 5.52B | |
+29.87% | 5.13B | |
-13.89% | 4.49B |
- Stock Market
- Equities
- HEKTS Stock
- News Hektas Ticaret T.A.S.
- Hektas Ticaret T.A.S. decided to acquire ARMA ILAÇ from OYAK BIYOTEKNOLOJI for TRY 92 million.